Lazard Asset Management
CRGX

Lazard Asset Management’s CARGO Therapeutics CRGX Stock Holding History

Lazard Asset Management’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32
Closed – – 2347
2024
Q4 		$0 Hold
32
– – ﹤0.01% 2327
2024
Q3 		$0 Hold
32
– – ﹤0.01% 2298
2024
Q2 		$0 Buy
+32
New +$608 ﹤0.01% 2262

Other funds holding CRGX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGV
TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

Lazard Asset Management's CRGX Position: Q1 2025 in Review

Lazard Asset Management sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 32 shares.

Lazard Asset Management first reported a position in CRGX in Q2 2024 and held it in 3 quarters. The position peaked at $0 in Q4 2024. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

  • Lazard Asset Management reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 32 CARGO Therapeutics shares in Q1 2025.
  • Lazard Asset Management first reported a position in CARGO Therapeutics in Q2 2024 and held it in 3 quarters.
  • Lazard Asset Management's CARGO Therapeutics position peaked at $0 in Q4 2024.
  • 113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.